Type 2 Diabetes Trial, Recruiting NCT06078683 Sponsor: Ohio State University Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT06078683
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 80 years old
  • People who have been diagnosed with Type 2 Diabetes
  • People whose medical treatment has been stable for at least 1 month, with no planned changes between the two testing sessions, as determined by their treating doctor
  • People whose water tablet (diuretic) dose may have changed, as long as it has been stable for at least 1 week before the start of the trial
  • People with a Body Mass Index (BMI) of 25 or higher
  • People who are able to do a walking test on a treadmill (only if that specific test is part of their participation)
  • People who are able to read and sign a consent form

Who may not be able to join:

  • Women who are pregnant, currently breastfeeding, or planning to become pregnant during the trial
  • People with a known allergy or sensitivity to a type of dye used in MRI scans called gadolinium-based contrast agents
  • People who have an implanted heart device, such as a pacemaker, defibrillator, cardiac resynchronization device, or a mechanical heart pump (left ventricular assist device)
  • People who have other metal implants or surgical clips in their body that are not safe for MRI scans
  • People who experience claustrophobia (fear of enclosed spaces)
  • People with a history of severe kidney disease (with a kidney function score below 30 ml/kg/1.73m²) (confirm with trial site)
  • People who have Type 1 Diabetes
  • People with a history of a serious diabetes-related complication called diabetic ketoacidosis
  • People who have been diagnosed with a lung disease that requires ongoing oxygen use
  • People with a BMI below 25
  • People who have had a major surgical procedure within the 90 days before screening, or who have a major planned surgery scheduled within 90 days after screening
  • People with active or chronic liver disease, where certain liver-related blood test results are more than three times higher than the normal range at the time of screening
  • People who have had stomach or bowel surgery, or who have a digestive condition that could interfere with taking the study supplement — though people who have had weight-loss surgery may be eligible if their weight has been stable for the past 3 months
  • People with an active cancer diagnosis, or a history of cancer in the past 2 years — with some exceptions for certain low-risk or treated skin, cervical, or prostate cancers (confirm with trial site)
  • People who have any condition other than diabetes that means they are not expected to live for more than 1 year, in the opinion of the trial doctor
  • People who are currently taking part in another clinical trial of an investigational drug or device, or who have completed such a trial within the past 30 days
  • People with chronic alcohol or drug misuse, or any condition that the trial doctor believes would make it unlikely they could complete the trial
  • People with any other health condition that the trial doctor believes could put them at risk during the trial or prevent them from following the trial plan
  • People who are unwilling or unable to follow the instructions for their assigned supplement group
  • People who have an allergy to any ingredient in the study supplement, or who are lactose intolerant
  • People who are currently following a low-carbohydrate diet — a 30-day period off the diet would be required before joining
  • People who decline to give their consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yuchi Han, MD, MMSc, Ohio State University

Phone: 614-688-5623

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ohio State University
Registry
ClinicalTrials.gov
Start date
6 June 2023
Est. completion
31 August 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Cardiac MRI measures of cardiac function

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov